Jason Haas

Affiliations

  • Director at Ligand Pharmaceuticals Inc (LGND), 2026-08-14
  • Chief Financial Officer at Odyssey Therapeutics Inc. (ODTX), 2026-05-12
  • Chief Financial Officer at Syros Pharmaceuticals Inc. (SYRS), 2024-11-20
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ODTX $20.00 1,000 $20,000.00 62,908 2026-05-08 Filing
SYRS $1.68 45,344 $76,005.61 124,552 2024-09-12 Filing
SYRS $1.58 19,293 $30,446.28 79,208 2024-09-11 Filing
SYRS $1.55 35,363 $54,787.90 59,915 2024-09-10 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LGND $292.81 7,138 $2,090,062.08 3,981 2026-08-12 Filing
LGND $256.08 3,461 $886,286.30 4,981 2026-06-12 Filing
LGND $255.01 3,000 $765,033.90 8,442 2026-06-12 Filing
SYRS $0.21 137,803 $28,979.97 0 2024-11-18 Filing